{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "76162-801",
      "generic_name": "guaifenesin and pseudoephedrine hydrochloride",
      "labeler_name": "Topco Associates LLC",
      "brand_name": "topcare mucus d",
      "active_ingredients": [
        {
          "name": "GUAIFENESIN",
          "strength": "600 mg/1"
        },
        {
          "name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
          "strength": "60 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "76162-801-89",
          "description": "1 BLISTER PACK in 1 CARTON (76162-801-89)  / 18 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20230816",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, MULTILAYER, EXTENDED RELEASE",
      "spl_id": "1a640e24-6d3d-4c6b-b06b-6dbc311974e2",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230816",
      "product_id": "76162-801_1a640e24-6d3d-4c6b-b06b-6dbc311974e2",
      "application_number": "ANDA214407",
      "brand_name_base": "topcare mucus d",
      "pharm_class": [
        "Adrenergic alpha-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "alpha-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}